(19)
(11) EP 4 824 033 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24841037.5

(22) Date of filing: 11.12.2024
(51) International Patent Classification (IPC): 
C07C 219/06(2006.01)
A61K 9/51(2006.01)
(52) Cooperative Patent Classification (CPC):
C07C 219/06; A61K 9/5123; C12N 15/88
(86) International application number:
PCT/US2024/059558
(87) International publication number:
WO 2025/128696 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 12.12.2023 US 202363609107 P

(71) Applicant: Acuitas Therapeutics, Inc.
Vancouver, British Columbia V6T 1Z3 (CA)

(72) Inventor:
  • ANSELL, Steven M.
    Vancouver, British Columbia V6T 1Z3 (CA)

(74) Representative: Grünecker Patent- und Rechtsanwälte PartG mbB 
Leopoldstraße 4
80802 München
80802 München (DE)

   


(54) CATIONIC LIPID COMPOUNDS FOR USE IN LIPID NANOPARTICLES